Search alternatives:
significantly observed » significantly altered (Expand Search), significantly clustered (Expand Search), significantly preferred (Expand Search)
significant difference » significant differences (Expand Search)
observed decrease » observed decreased (Expand Search)
difference doses » different doses (Expand Search), difference scores (Expand Search), difference tests (Expand Search)
Showing 41 - 60 results of 29,694 for search '(( significantly observed decrease ) OR ( significant difference doses ))', query time: 0.72s Refine Results
  1. 41
    Bias risk assessments for each RCS study.

    Bias risk assessments for each RCS study. by Xin Liu (43569)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  2. 42
    Proportion of CD25<sup>+</sup>CD27<sup>-</sup> cells among CD3<sup>-</sup>CD11b<sup>+</sup> cells according to the dose of anti-thymocyte globulin.

    Proportion of CD25<sup>+</sup>CD27<sup>-</sup> cells among CD3<sup>-</sup>CD11b<sup>+</sup> cells according to the dose of anti-thymocyte globulin. by Youngmin Ko (3333819)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  3. 43
    Significant clusters for zero-dose children aged 12-23 months in Ethiopia, 2023.

    Significant clusters for zero-dose children aged 12-23 months in Ethiopia, 2023. by Berhanu Fikadie Endehabtu (9218109)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  4. 44
    Join-point regression analysis of the statistically significant linear increase in use of antidepressants during the observed time period.

    Join-point regression analysis of the statistically significant linear increase in use of antidepressants during the observed time period. by Jelena Filimonovic (22305307)

    Published 2025
    Save to List
    Saved in:
  5. 45
    Proportion of CD25<sup>+</sup>CD16<sup>low</sup> cells among CD3<sup>-</sup>CD11b<sup>+</sup> cells according to the dose of anti-thymocyte globulin.

    Proportion of CD25<sup>+</sup>CD16<sup>low</sup> cells among CD3<sup>-</sup>CD11b<sup>+</sup> cells according to the dose of anti-thymocyte globulin. by Youngmin Ko (3333819)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  6. 46
    Mean of patients with confirmed SARS-COV-2 infection from February to 15 July in Libya, (*): High significant different (a p-value <0.05 was considered significant); (**): Very high significant different (a p-value <0.05 was considered significant).

    Mean of patients with confirmed SARS-COV-2 infection from February to 15 July in Libya, (*): High significant different (a p-value <0.05 was considered significant); (**): Very hig... by Mohamed Hadi Mohamed Abdelhamid (13930518)

    Published 2022
    Save to List
    Saved in:
  7. 47
    Longitudinal salivary antibody profile of SARS-CoV-2-specific IgG in 23 study participants at an extended collection timepoint.

    Longitudinal salivary antibody profile of SARS-CoV-2-specific IgG in 23 study participants at an extended collection timepoint. by Kenny Nguyen (7361624)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  8. 48
    SARS-CoV-2 salivary IgA and IgG titers after mRNA-1273 vaccination—comparison between <60 years old and 60+ years old age groups.

    SARS-CoV-2 salivary IgA and IgG titers after mRNA-1273 vaccination—comparison between <60 years old and 60+ years old age groups. by Kenny Nguyen (7361624)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  9. 49
    Individual salivary IgA and IgG titers.

    Individual salivary IgA and IgG titers. by Kenny Nguyen (7361624)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  10. 50
    Demographic summary of enrolled participants (n = 200).

    Demographic summary of enrolled participants (n = 200). by Kenny Nguyen (7361624)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  11. 51
    Study design and sample collection.

    Study design and sample collection. by Kenny Nguyen (7361624)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  12. 52
    SARS-CoV-2 salivary IgA and IgG titers after mRNA-1273 vaccination—comparison by gender.

    SARS-CoV-2 salivary IgA and IgG titers after mRNA-1273 vaccination—comparison by gender. by Kenny Nguyen (7361624)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  13. 53
    Multiplex serology assay results for spike, nucleocapsid, and RBD proteins in blood samples (<i>n =</i> 127) collected 42 days after the first vaccine dose.

    Multiplex serology assay results for spike, nucleocapsid, and RBD proteins in blood samples (<i>n =</i> 127) collected 42 days after the first vaccine dose. by Kenny Nguyen (7361624)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  14. 54
    SARS-CoV-2 salivary IgA and IgG titers after mRNA-1273 vaccination–comparison by race.

    SARS-CoV-2 salivary IgA and IgG titers after mRNA-1273 vaccination–comparison by race. by Kenny Nguyen (7361624)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  15. 55
    SARS-CoV-2-specific IgA and IgG salivary antibody profiles upon receiving mRNA-1273 vaccine.

    SARS-CoV-2-specific IgA and IgG salivary antibody profiles upon receiving mRNA-1273 vaccine. by Kenny Nguyen (7361624)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  16. 56
    Gut richness and diversity decrease significantly by week 5 of chemoradiotherapy.

    Gut richness and diversity decrease significantly by week 5 of chemoradiotherapy. by Molly B. El Alam (10231830)

    Published 2021
    Save to List
    Saved in:
  17. 57
    Dynamic Tracking of <i>In Vivo</i> Receptor Availability in Tumor Using Paired-Agent Imaging

    Dynamic Tracking of <i>In Vivo</i> Receptor Availability in Tumor Using Paired-Agent Imaging by Yichen Feng (450964)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  18. 58
    Dynamic Tracking of <i>In Vivo</i> Receptor Availability in Tumor Using Paired-Agent Imaging

    Dynamic Tracking of <i>In Vivo</i> Receptor Availability in Tumor Using Paired-Agent Imaging by Yichen Feng (450964)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  19. 59
    Dynamic Tracking of <i>In Vivo</i> Receptor Availability in Tumor Using Paired-Agent Imaging

    Dynamic Tracking of <i>In Vivo</i> Receptor Availability in Tumor Using Paired-Agent Imaging by Yichen Feng (450964)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  20. 60
    Cluster plot for different doses and exposure times:

    Cluster plot for different doses and exposure times: by Maria Antonietta Ferrara (14539517)

    Published 2025
    Save to List
    Saved in:

Search Tools: